Biotech China 2014

Peptides: University of Texas, MD Anderson

Total Score People Score Events Score
21 18 10
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Drug Discovery in Industry, Academia, and Government: What Is the Track Record? Michael A. White
Clinical Trial Design in the Genomic Era Co-Chairpersons: Donald A. Berry, The University of Texas MD Anderson Cancer Center, Houston, TX, and George W. Sledge, Jr., Stanford University School of Medicine, Stanford, CA Donald Berry
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Gordon Mills
Bridging the Gap Between Clinical Research and Laboratory Investigation: Utilizing Presurgical Clinical Trials to Investigate Anti-CTLA-4 Immunotherapy Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, TX Padmanee Sharma
Whole Body Metabolism and Cancer Chairperson: Philipp E. Scherer, UT Southwestern Medical Center, Dallas, TX Philipp Scherer
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY George A. Calin
Identifying Novel Redox Signaling Pathways for Cancer Chemoprevention: From Fly to the Mouse Garth Powis, The University of Texas MD Anderson Cancer Center, Houston, TX Garth Powis
PAK Family of Kinases in Human Cancer: Past, Present, and Future Rakesh Kumar, George Washington University, Washington, DC Rakesh Kumar
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) Th17 Cells Contribute to Intestinal Homeostasis by Inducing Intestinal IgA and pIgR Expression Anthony Cao
January 25, 2009 17th International Symposium on Regulatory Peptides Novel modifications of gut regulatory peptides Joseph Goldstein
July 20, 2008 WORLD SUMMIT OF ANTIVIRALS Combating Severe Viral Infections Session 2: Etiology and Epidemiology of Viral Infections R. Palmer Beasley
Session 3: Epidemiology and Virology Lu-Yu Hwang
Epidemiology and Prevention of HIV, HBV and HCV Infection among Hard to Reach Drug Users: Experiences from the Inner City Neighborhoods of the United States Lu-Yu Hwang
May 1, 2008 Monoclonal Antibodies Patentability of Antibodies in the United States Thomas J. Kowalski
April 27, 2008 Phage Display of Antibodies and Peptides Engineering Aglycosylated Antibodies with Effector Functions George Georgiou
Ligand-Directed Vascular Targeting and Molecular Imaging Renata Pasqualini
April 27, 2008 Phage Display of Antibodies and Peptides Engineering Aglycosylated Antibodies with Effector Functions George Georgiou
Ligand-Directed Vascular Targeting and Molecular Imaging Renata Pasqualini
March 2, 2008 VIRAL VECTORS FOR GENE THERAPY, THE SCIENCE OF Ligand-Directed Vascular Targeting and Molecular Imaging Renata Pasqualini
February 17, 2008 GRC - Peptides, Chemistry & Biology Of Monitoring and Manipulating the Proteome With Peptoids Thomas Kodadek
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 2: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part I) (13:30-17:30) Dr. Xiaodong Cheng
session 2: Identification of Selective Anti-pancreatic Cancer Inhibitors Using Synthetic Lethal Chemical Screening (14:30-14:50) Dr. Xiaodong Cheng
Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Stanley J. Watowich
Session 11: Global Grid-computing Initiative to Discover Novel Dengue and Hepatitis C Antivirals (09:40-10:00) Stanley J. Watowich
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.